KTTA vs AAPL: Which Stock is Better?
Side-by-side comparison of Pasithea Therapeutics Corp and Apple Inc in 2026
KTTA
Pasithea Therapeutics Corp
$0.74
AAPL
Apple Inc
$270.52
Key Metrics Comparison
| Metric | KTTA | AAPL | Winner |
|---|---|---|---|
| Market Cap | $18.36M | N/A | KTTA |
| P/E Ratio | N/A | 33.32 | AAPL |
| EPS (TTM) | $N/A | $8.11 | AAPL |
| Revenue Growth | 15.0% | 0.2% | KTTA |
| Gross Margin | -0.5% | 47.3% | AAPL |
Analyze KTTA
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KTTA or AAPL a better investment?
Comparing KTTA and AAPL: Pasithea Therapeutics Corp has a market cap of $18.36M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KTTA and AAPL?
KTTA (Pasithea Therapeutics Corp) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KTTA or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KTTA or AAPL?
KTTA has higher revenue growth at 15.0% vs 0.2% for AAPL.
Which company is more profitable: KTTA or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to -0.5% for KTTA.
Which is the larger company: KTTA or AAPL?
Pasithea Therapeutics Corp (KTTA) is larger with a market cap of $18.36M compared to N/A for AAPL.
Should I buy KTTA or AAPL in 2026?
Both KTTA and AAPL have investment merit. KTTA trades at $0.74 while AAPL trades at $270.52. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KTTA and AAPL stock?
Key differences: Market Cap ($18.36M vs N/A), P/E Ratio (N/A vs 33.3x), Revenue Growth (15.0% vs 0.2%), Gross Margin (-0.5% vs 47.3%).